Strategic Industrial Sourcing: Powering GCC Pharma Localization.

Validated, SFDA-Ready APIs and Excipients from Elite German Manufacturers.

Request a Sourcing Audit Review Technical Capabilities

Beyond Procurement:
A Technical Bridge for Sovereign Manufacturing

SFDA & MoHAP Readiness

Skip the 6–12 month trial and error. We do not just find suppliers; we pre-audit German Site Master Files (SMF) to guarantee immediate compliance with KSA Vision 2030 and UAE Operation 300bn localization mandates

The Technical Translator

We seamlessly align European dossiers into the precise Common Technical Document (CTD) format required by Gulf authorities, ensuring zero registration delays.

Climatic Zone IVb Alignment

We eliminate stability testing failures before importation begins. We ensure your German source provides raw materials and APIs backed by robust stability data explicitly validated for the extreme hot and humid zones (30°C / 75% RH) of the Middle East.

Our § 52c AMG Mediation Advantage

GMP & SMF Pre-Validation (The Entry Key)

Pre-verified German sources. Validated science

Pre-audits of European Site Master Files (SMFs) for target market readiness.
Validation powered by our founder’s 10 years of direct experience in German Biopharma Quality Assurance (QA) and GMP.
Full management of consular legalization processes for GCC registration.

Driven by our deep internal QA experience, Levant Gate Pharma UG performs rigorous pre-mediation audits of elite German chemical manufacturers. We ensure their SMF and legalized GMP certificates are strictly recognized by your target Ministry of Health, transforming high-risk procurement into a seamless regulatory handover.

Asset-Light Brokerage (§ 52c AMG)

Direct B2B contracting. Zero hidden markups.

Operating strictly under German Law § 52c AMG as a specialized mediator.
Levant Gate Pharma takes no legal title to APIs, providing a “Clean Interface”.
Eliminates opaque middleman markups, ensuring optimal factory-direct pricing.

Traditional pharmaceutical wholesalers assume high-liability risks and hide margins during cross-border trade. Levante Gate Pharma UG is a Service and Compliance Partner, not a wholesaler. By facilitating direct commercial invoicing between the German manufacturer and the Middle Eastern industrial buyer, we guarantee pricing transparency and legal integrity

Strategic Industrial Allocations

Track 1: Industrial Sourcing (APIs, Excipients & Starting Materials)

Target Market

Strategic Rationale

Our Sourcing Focus & Deliverables

Saudi Arabia (KSA)

(Vision 2030 Mandate)

Industrial Localization Shift:

Aggressive government-driven transition from importing finished pharmaceuticals to domestic manufacturing…

Sourcing SFDA-ready APIs and excipients compliant with Climatic Zone IVb (30°C/75% RH) data.
Pre-auditing German Site Master Files (SMF) to eliminate dossier rejections.
Managing complex consular legalization of GMP certificates at the KSA Embassy in Berlin.

United Arab Emirates (UAE)

(Operation 300bn)

Sovereign Base Expansion:

Rapid scaling of local production capacities requiring seamless, highly digitized supply lines and trusted European primary or secondary sources.

Delivering high-grade starting materials to fuel local UAE manufacturing plants.
Technical translation of European Drug Master Files (DMF) into localized CTD Module 3 formats.
Securing raw materials fully pre-validated for future regional export compliance.

Syria & Levant

(Industrial Rebuilding)

Factory Reconstruction:

Re-establishing disrupted local production facilities facing severe obstacles navigating European export controls, sanctions, and trade finance.

Executing rigorous chemical pre-clearance under EU Regulation 2021/821 to ensure materials are not classified as dual-use precursors.
Navigating EU Council Reg 36/2012 to establish bulletproof legal export channels.
Securing and auditing physical End-User Certifications (EUCs) to provide absolute “Ethical Shielding.”

Frequently Asked Questions on Clinical Market Access

Product registration in the GCC requires meticulous dossier preparation. We assist European manufacturers in formatting their clinical data, stability studies, and pricing certificates to align with the specific eCTD (Electronic Common Technical Document) requirements of the Saudi SFDA, UAE MoHAP, and other regional authorities. We act as the technical liaison between the manufacturer and the local authorized representative.

As a § 52c AMG mediator, LGP does not operate physical warehouses or logistics fleets. We broker the direct contract between the European manufacturer and the Middle Eastern buyer. However, as part of our Quality Assurance protocol, we rigorously audit the designated freight forwarders and regional distributors to ensure they hold valid Good Distribution Practice (GDP) certifications necessary for handling cold-chain biologics.

To maintain the absolute integrity of our compliance shield and eliminate any conflict of interest with primary research ecosystems, LGP enforces a strict, voluntary Therapeutic Negative List. We categorically refuse the mediation of narcotics (BtM), psychoactive substances, unverified nutritional supplements, and aesthetic products. Furthermore, we exclude highly innovative, patented portfolios in Respiratory (LAMA/LABA/ICS) and Cardiometabolism (SGLT2 inhibitors/NOACs). Our resources are dedicated 100% to essential standard generics, vital life-saving therapeutics, and validated medical technology.

Secure Your Technical Consultation

Use the form below to outline your product portfolio (Standard Generics, Biosimilars, or Med-Tech hardware), and our lead consultant will contact your regulatory team within 24 business hours.